1001 related articles for article (PubMed ID: 27424807)
1. Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.
Roberts EW; Broz ML; Binnewies M; Headley MB; Nelson AE; Wolf DM; Kaisho T; Bogunovic D; Bhardwaj N; Krummel MF
Cancer Cell; 2016 Aug; 30(2):324-336. PubMed ID: 27424807
[TBL] [Abstract][Full Text] [Related]
2. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
[TBL] [Abstract][Full Text] [Related]
3. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
[TBL] [Abstract][Full Text] [Related]
4. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.
Stoitzner P; Green LK; Jung JY; Price KM; Atarea H; Kivell B; Ronchese F
Cancer Immunol Immunother; 2008 Nov; 57(11):1665-73. PubMed ID: 18311487
[TBL] [Abstract][Full Text] [Related]
5. Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells.
González FE; Ortiz C; Reyes M; Dutzan N; Patel V; Pereda C; Gleisner MA; López MN; Gutkind JS; Salazar-Onfray F
Immunology; 2014 Jul; 142(3):396-405. PubMed ID: 24673602
[TBL] [Abstract][Full Text] [Related]
6. Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells.
Ruhland MK; Roberts EW; Cai E; Mujal AM; Marchuk K; Beppler C; Nam D; Serwas NK; Binnewies M; Krummel MF
Cancer Cell; 2020 Jun; 37(6):786-799.e5. PubMed ID: 32516589
[TBL] [Abstract][Full Text] [Related]
7. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.
Johansson-Lindbom B; Svensson M; Pabst O; Palmqvist C; Marquez G; Förster R; Agace WW
J Exp Med; 2005 Oct; 202(8):1063-73. PubMed ID: 16216890
[TBL] [Abstract][Full Text] [Related]
8. Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells.
Gerner MY; Mescher MF
J Immunol; 2009 Mar; 182(5):2726-37. PubMed ID: 19234167
[TBL] [Abstract][Full Text] [Related]
9. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells.
Ho AW; Prabhu N; Betts RJ; Ge MQ; Dai X; Hutchinson PE; Lew FC; Wong KL; Hanson BJ; Macary PA; Kemeny DM
J Immunol; 2011 Dec; 187(11):6011-21. PubMed ID: 22043017
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor NR4A3 controls CD103+ dendritic cell migration.
Park K; Mikulski Z; Seo GY; Andreyev AY; Marcovecchio P; Blatchley A; Kronenberg M; Hedrick CC
J Clin Invest; 2016 Dec; 126(12):4603-4615. PubMed ID: 27820700
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
12. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Salmon H; Idoyaga J; Rahman A; Leboeuf M; Remark R; Jordan S; Casanova-Acebes M; Khudoynazarova M; Agudo J; Tung N; Chakarov S; Rivera C; Hogstad B; Bosenberg M; Hashimoto D; Gnjatic S; Bhardwaj N; Palucka AK; Brown BD; Brody J; Ginhoux F; Merad M
Immunity; 2016 Apr; 44(4):924-38. PubMed ID: 27096321
[TBL] [Abstract][Full Text] [Related]
13. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
14. Tissue-resident memory CD8
Menares E; Gálvez-Cancino F; Cáceres-Morgado P; Ghorani E; López E; Díaz X; Saavedra-Almarza J; Figueroa DA; Roa E; Quezada SA; Lladser A
Nat Commun; 2019 Sep; 10(1):4401. PubMed ID: 31562311
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
16. L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells.
Guarda G; Hons M; Soriano SF; Huang AY; Polley R; Martín-Fontecha A; Stein JV; Germain RN; Lanzavecchia A; Sallusto F
Nat Immunol; 2007 Jul; 8(7):743-52. PubMed ID: 17529983
[TBL] [Abstract][Full Text] [Related]
17. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
[TBL] [Abstract][Full Text] [Related]
18. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node.
Hintzen G; Ohl L; del Rio ML; Rodriguez-Barbosa JI; Pabst O; Kocks JR; Krege J; Hardtke S; Förster R
J Immunol; 2006 Nov; 177(10):7346-54. PubMed ID: 17082654
[TBL] [Abstract][Full Text] [Related]
19. Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.
Zhang Y; Chen G; Liu Z; Tian S; Zhang J; Carey CD; Murphy KM; Storkus WJ; Falo LD; You Z
J Immunol; 2015 Jun; 194(12):5937-47. PubMed ID: 25972487
[TBL] [Abstract][Full Text] [Related]
20. Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141
Huang J; Zhou J; Ghinnagow R; Seki T; Iketani S; Soulard D; Paczkowski P; Tsuji Y; MacKay S; Cruz LJ; Trottein F; Tsuji M
Front Immunol; 2020; 11():2043. PubMed ID: 32973811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
